Ken Fisher started to build up the position in Caredx in Q3 2019. Since then they sold 112 Thousand shares. The investor sold all their shares in Q4 2019 and doesn't own any shares in Caredx anymore.
HLA Typing for Transplant Market by Technology (PCR (SSO, SSP, Real Time), Sequencing (NGS, Sanger)), Product (Instrument, Reagent, Software), Application (C...
Tramways Monthly, almost 3 years agoHLA Typing for Transplant Market by Technology (PCR (SSO, SSP, Real Time), Sequencing (NGS, Sanger)), Product (Instrument, Reagent, Software), Application (C...
Jumbo News, almost 3 years agoDatabridgemarketresearch.com added a new study on Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Research Review 2020 that has been just made avai...
OpenPR, over 3 years agoA DBMR team makes use of simple language and easy to understand statistical images to provide thorough information and in-depth data on the industry and Glob...
OpenPR, over 3 years ago